CD274 and neoplasm: CS/MTO-Cu@AMI induces cuproptosis and mitochondrial dysfunction, activating the AMPK pathway to promote PD-L1 degradation. This nanocomplex also enhances anti-tumor immunity by stimulating the cGAS-STING pathway.